Edible Potentilla longifolia Shows Preventive Power Against Fatty Liver Disease

A leafy vegetable long eaten in Inner Mongolia and valued in traditional northeastern Chinese medicine may hold real preventive power against one of the fastest-growing liver disorders worldwide. In a study published in npj Science of Food, researchers at Yanbian University report that Potentilla longifolia, known locally as GYC, prevented the early stages of metabolic dysfunction-associated steatotic liver disease, or MASLD, in animals fed a high-fat diet. The team combined chemical profiling, network pharmacology, and untargeted metabolomics to trace exactly how the plant’s constituents rewire liver metabolism and inflammation, offering a molecular blueprint for a functional food approach to prevention.

MASLD, formerly known as non-alcoholic fatty liver disease, affects roughly a third of adults globally and begins silently as fat accumulates inside liver cells. If unchecked, the condition can progress to inflammation, fibrosis, and ultimately cirrhosis or liver cancer. Because the disease is driven by diet and metabolic imbalance rather than a single pathogen, prevention has become the central strategic goal. The Yanbian University group, led by corresponding authors Haidan Yuan and Guangchun Piao, argued that botanical resources with documented health benefits could serve as accessible prophylactic agents, and P. longifolia, a common edible vegetable in Inner Mongolia historically recognized in northeastern China for its health-promoting properties, was an obvious candidate to test.

The investigation began with a rigorous chemical census. Using ultra-high-performance liquid chromatography coupled to quadrupole-orbitrap mass spectrometry, or UHPLC-QE-MS, the researchers characterized 25 major bioactive constituents in the plant. This chemical blueprint served as the foundation for everything that followed. Each identified compound was then fed into a network pharmacology analysis, a computational strategy that maps interactions between bioactive molecules, their protein targets, and disease pathways. Rather than attributing an effect to one magic bullet, network pharmacology embraces the multi-component, multi-target logic that underlies most botanical interventions, and it allowed the team to predict which signaling hubs the plant’s constituents were most likely to engage.

To move from prediction to measurement, the researchers performed untargeted metabolomics on both serum and liver tissue from experimental animals. Metabolic profiling identified 18 differential metabolites in serum and 15 in liver tissue, a pattern that converged on two primary regulatory hubs: the AMPK axis and the NF-κB axis. AMPK, or AMP-activated protein kinase, functions as the cell’s energy sensor, switching on fat oxidation and shutting down lipogenesis when cellular energy status shifts. NF-κB, by contrast, is a transcription factor that orchestrates inflammatory responses, and its chronic activation in the liver is a hallmark of progression from simple steatosis to steatohepatitis. The metabolomics data suggested that P. longifolia was engaging both hubs simultaneously.

Experimental validation followed in vivo and in vitro. Animals given a high-fat diet developed obesity, hepatic steatosis, and early hepatic injury, the classic triad of emerging MASLD. When the diet was paired with GYC intervention, the researchers found that the plant effectively prevented high-fat diet-induced obesity, fat accumulation in the liver, and the earliest signs of hepatic damage. The findings, published on 15 October 2026 as an open-access article carrying the DOI 10.1038/s41538-026-01193-9, demonstrated that the intervention maintained lipid homeostasis and tempered early hepatic inflammatory responses by activating the AMPK signaling axis while suppressing the NF-κB and MAPK pathways.

The mechanistic picture that emerges is one of coordinated metabolic and inflammatory control. By activating AMPK, the plant’s constituents appear to restore the liver’s lipid-handling equilibrium, promoting fatty acid oxidation and limiting de novo lipogenesis, the process by which excess carbohydrate is converted into stored fat. By suppressing NF-κB and the MAPK cascade, another signaling family that propagates inflammatory signals, the intervention dampens the cytokine-driven inflammation that converts benign fat accumulation into active liver disease. Metabolomics confirmed that these pathway shifts were mirrored by measurable changes in circulating and hepatic metabolites, linking molecular signaling to the systemic metabolic state.

What makes the study technically notable is its integrated design. Chemical profiling supplied the compound inventory, network pharmacology predicted the target landscape, and metabolomics measured the actual metabolic consequences, with in vivo and in vitro experiments closing the loop. This triangulation reduces the risk that a single method’s artifacts drive the conclusion. The convergence of 18 serum and 15 liver differential metabolites on the AMPK and NF-κB axes, predicted independently by network pharmacology, provides a robust scientific rationale for utilizing GYC as a functional food resource or a promising prophylactic agent for MASLD prevention.

The work also carries cultural and agricultural weight. P. longifolia is not an exotic rainforest remedy but a vegetable already eaten regularly in Inner Mongolia, meaning the gap between laboratory finding and dietary practice is unusually narrow. The researchers, based in the College of Pharmacy at Yanbian University and the Key Laboratory of Natural Medicines of the Changbai Mountain under the Ministry of Education, framed the plant as a botanical resource historically recognized in northeastern China for its health-promoting benefits, and their data now give that recognition a molecular footing. The study was supported by the Jilin Province Science and Technology Development Plan Project and the National Natural Science Foundation of China.

For the global food science community, the findings arrive at a moment when MASLD prevention is urgently sought and dietary intervention remains the most practical lever. A vegetable that activates the liver’s energy sensor and quiets its inflammatory circuits, consumed as food rather than as a pill, represents a compelling model for functional food design. The Yanbian University team’s work suggests that the answer to a modern metabolic epidemic may have been growing on the Inner Mongolian plateau all along, waiting for metabolomics to reveal its mechanism.

Subject of Research: Preventive mechanisms of Potentilla longifolia against MASLD based on chemical profiling, network pharmacology, and metabolomics

Article Title: Preventive mechanisms of Potentilla longifolia against MASLD based on chemical profiling, network pharmacology, and metabolomics

Article References: Lin, S., Zhang, L., Wang, Z., Li, J., Cui, H., Bao, F., Di, Y., Xu, C., Dai, T., Yuan, H., & Piao, G. (2026). Preventive mechanisms of Potentilla longifolia against MASLD based on chemical profiling, network pharmacology, and metabolomics. npj Science of Food. https://doi.org/10.1038/s41538-026-01193-9

Image Credits: AI Generated

DOI: 10.1038/s41538-026-01193-9

Keywords: Preventive, mechanisms, Potentilla, longifolia, against, MASLD, based, chemical, profiling, network, pharmacology, metabolomics